105 related articles for article (PubMed ID: 23992378)
1. Estetrol, molecular chaperones, and the epigenetics of longevity and cancer resistance.
Krøll J
Rejuvenation Res; 2014 Apr; 17(2):157-8. PubMed ID: 23992378
[TBL] [Abstract][Full Text] [Related]
2. Molecular chaperones and the epigenetics of longevity and cancer resistance.
Krøll J
Ann N Y Acad Sci; 2007 Apr; 1100():75-83. PubMed ID: 17460166
[TBL] [Abstract][Full Text] [Related]
3. Bile acids, chaperones, and mammalian longevity.
Krøll J
Rejuvenation Res; 2012 Apr; 15(2):210-2. PubMed ID: 22533434
[TBL] [Abstract][Full Text] [Related]
4. Chaperones and longevity.
Krøll J
Biogerontology; 2005; 6(5):357-61. PubMed ID: 16463112
[TBL] [Abstract][Full Text] [Related]
5. Correlations of plasma cortisol levels, chaperone expression and mammalian longevity: a review of published data.
Krøll J
Biogerontology; 2010 Aug; 11(4):495-9. PubMed ID: 20111999
[TBL] [Abstract][Full Text] [Related]
6. Molecular chaperones and the aging process.
Sóti C; Csermely P
Biogerontology; 2000; 1(3):225-33. PubMed ID: 11707899
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone, molecular chaperones and the epigenetics of primate longevity.
Krøll J
Rejuvenation Res; 2015 Aug; 18(4):341-346. PubMed ID: 25706901
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic and mitochondrial mechanisms in aging and longevity: a report of a meeting of the Longevity Consortium, Napa, California, October 25-27, 2006.
Kahn AJ
J Gerontol A Biol Sci Med Sci; 2007 Jun; 62(6):577-82. PubMed ID: 17595412
[No Abstract] [Full Text] [Related]
9. Targeting chromatin aging - The epigenetic impact of longevity-associated interventions.
Field AE; Adams PD
Exp Gerontol; 2017 Aug; 94():29-33. PubMed ID: 27986499
[TBL] [Abstract][Full Text] [Related]
10. Nutritional influence on epigenetics and effects on longevity.
Niculescu MD; Lupu DS
Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):35-40. PubMed ID: 21088573
[TBL] [Abstract][Full Text] [Related]
11. Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation.
Gérard C; Blacher S; Communal L; Courtin A; Tskitishvili E; Mestdagt M; Munaut C; Noel A; Gompel A; Péqueux C; Foidart JM
J Endocrinol; 2015 Jan; 224(1):85-95. PubMed ID: 25359896
[TBL] [Abstract][Full Text] [Related]
12. Ovulation inhibition by estetrol in an in vivo model.
Coelingh Bennink HJ; Skouby S; Bouchard P; Holinka CF
Contraception; 2008 Mar; 77(3):186-90. PubMed ID: 18279689
[TBL] [Abstract][Full Text] [Related]
13. Chaperonopathies of senescence and the scrambling of interactions between the chaperoning and the immune systems.
Macario AJ; Cappello F; Zummo G; Conway de Macario E
Ann N Y Acad Sci; 2010 Jun; 1197():85-93. PubMed ID: 20536837
[TBL] [Abstract][Full Text] [Related]
14. Geroprotection by glycerol: insights to its mechanisms and clinical potentials.
Deocaris CC; Shrestha BG; Kraft DC; Yamasaki K; Kaul SC; Rattan SI; Wadhwa R
Ann N Y Acad Sci; 2006 May; 1067():488-92. PubMed ID: 16804031
[TBL] [Abstract][Full Text] [Related]
15. Protein homeostasis and molecular chaperones in aging.
Arslan MA; Csermely P; Soti C
Biogerontology; 2006; 7(5-6):383-9. PubMed ID: 16964526
[TBL] [Abstract][Full Text] [Related]
16. A prospective epigenetic paradigm between cellular senescence and epithelial-mesenchymal transition in organismal development and aging.
Kishi S; Bayliss PE; Hanai J
Transl Res; 2015 Jan; 165(1):241-9. PubMed ID: 24924348
[TBL] [Abstract][Full Text] [Related]
17. Molecular chaperones and protein-folding catalysts as intercellular signaling regulators in immunity and inflammation.
Henderson B; Pockley AG
J Leukoc Biol; 2010 Sep; 88(3):445-62. PubMed ID: 20445014
[TBL] [Abstract][Full Text] [Related]
18. Molecular chaperone functions in protein folding and proteostasis.
Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 at the crossroads of genetics and epigenetics.
Wong KS; Houry WA
Cell Res; 2006 Sep; 16(9):742-9. PubMed ID: 16940964
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism.
Visser M; Foidart JM; Coelingh Bennink HJ
Climacteric; 2008; 11 Suppl 1():64-8. PubMed ID: 18464025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
